Table of contents

Ovarian Cancer

• Survival Rates for International Federation of Gynecology and Obstetrics Stage III Ovarian Carcinoma by Cell Type: A Study of 262 Unselected Patients With Uniform Pathologic Review (1 March, 2012)

  Jeffrey D. Seidman, Anna Yemelyanova, Jonathan A. Cosin, Anthony Smith, Robert J. Kurman
• The N-Terminally Truncated p53 Isoform Δ40p53 Influences Prognosis in Mucinous Ovarian Cancer (1 March, 2012)

  Gerda Hofstetter, Astrid Berger, Regina Berger, Arijana Zorić, Elena I. Braicu, Daniel Reimer, Heidi Fiegl, Christian Marth, Alain G. Zeimet, Hanno Ulmer, Ute Moll, Robert Zeillinger, Nicole Concin
• Prognostic Value of Residual Tumor Size in Patients With Epithelial Ovarian Cancer FIGO Stages IIA–IV: Analysis of the OVCAD Data (1 March, 2012)

  Stephan Polterauer, Ignace Vergote, Nicole Concin, Ioana Braicu, Radoslav Chekerov, Sven Mahner, Linn Woelber, Isabelle Cadron, Toon Van Gorp, Robert Zeillinger, Dan Cacsire Castillo-Tong, Jalid Sehouli
• Increased Expression of Dachshund Homolog 1 in Ovarian Cancer as a Predictor for Poor Outcome (1 March, 2012)

  Fei Liang, Qingtao Lü, Shuyu Sun, Jie Zhou, Vladimir M. Popov, Shaoru Li, Weihua Li, Yang Liu, Jie Jiang, Beihua Kong
• Long-Term Clinical Outcome of Patients With Recurrent Epithelial Ovarian Carcinoma: Is it the Same for Each Histological Type? (1 March, 2012)

  Hiroaki Kajiyama, Kiyosumi Shibata, Mika Mizuno, Tomokazu Umezu, Shiro Suzuki, Eiko Yamamoto, Sawako Fujiwara, Michiyasu Kawai, Tetsuro Nagasaka, Fumitaka Kikkawa
• Accuracy of Frozen-Section Diagnosis of Ovarian Mucinous Tumors (1 March, 2012)

  Tip Pongsuvareeyakul, Surapan Khunamornpong, Jongkolnee Settakorn, Kornkanok Sukpan, Prapaporn Suprasert, Sumalee Siriaunkgul
• Role of Neoadjuvant Chemotherapy in the Management of Stage IIIC–IV Ovarian Cancer: Survey Results from the Members of the European Society of Gynecological Oncology (1 March, 2012)

  Sarah Cornelis, Ben Van Calster, Frederic Amant, Karin Leunen, Ate Gerard Jan van der Zee, Ignace Vergote